Kura Oncology
KURA
KURA
98 hedge funds and large institutions have $442M invested in Kura Oncology in 2018 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+22
Holders Change %
+28.95%
% of All Funds
2.25%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
31
Increased
33
Reduced
22
Closed
8
Calls
$17K
Puts
$49K
Net Calls
-$32K
Net Calls Change
-$35K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$44.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$9.2M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$6.19M |
| 4 |
SCM
Sio Capital Management
New York
|
+$4.98M |
| 5 |
Millennium Management
New York
|
+$4.09M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$7.74M |
| 2 |
Morgan Stanley
New York
|
-$3.35M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.65M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$2.44M |
| 5 |
NC
Nexthera Capital
New York
|
-$1.75M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SH
101
Sandia Holdings
Greenwich,
Connecticut
| – | -$922K | -60,240 | Closed |
|
|
PVI
102
Pura Vida Investments
New York
| – | -$765K | -50,000 | Closed |
|
|
DCM
103
Delpha Capital Management
New York
| – | -$23K | -1,479 | Closed |
|
|
PCM
104
Prelude Capital Management
New York
| – | -$14K | -900 | Closed |
|
105
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$9K | -600 | Closed |
|
106
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -94 | Closed |
|